• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于干细胞的治疗艺术。

The Art of Stem Cell-Based Therapy.

机构信息

Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.

出版信息

Adv Exp Med Biol. 2023;1420:1-12. doi: 10.1007/978-3-031-30040-0_1.

DOI:10.1007/978-3-031-30040-0_1
PMID:37258780
Abstract

Potency assays represent crucial experiments at the hub of the comprehensive complexity surrounding cell therapy. Moreover, numerous factors beyond biological and scientific considerations are involved in achieving successful potency assays that fulfil regulatory authority approval for a new advanced therapy medicinal product. Though this can mean a frustratingly long period of discovery and development, progress in cell therapy is nowadays proceeding remarkably quickly, assisted by the potency assay rigorously placing emphasis on the need to critically analyse the key factor/s responsible for the therapeutic mechanism of action. History has shown that it can take many decades for there to be an improved understanding of a mechanism of action. Yet the chasing of precise targets has revolutionised medicine, with no clearer example than approaches to viral pandemics. The centuries involved in the eradication of smallpox have paved the way for an unprecedented pace of vaccine development for the Covid-19 pandemic. Such extraordinary accomplishments foster encouragement that similarly for stem cell-based therapy, our scientific knowledge will continue to improve apace. This chapter focuses on the art of experimentation and discovery, introducing potency assay requisites and numerous factors that can influence potency assay outcomes. A comprehensive understanding of potency assays and their development can hasten the provision of new cell therapies to help resolve burdensome diseases of unmet medical need.

摘要

效力测定代表着细胞治疗领域综合复杂性的核心实验。此外,除了生物学和科学方面的考虑因素外,还有许多其他因素会影响到成功进行效力测定,从而获得新的先进治疗药物产品的监管机构批准。虽然这可能意味着需要经过一段令人沮丧的漫长发现和开发期,但如今细胞治疗的进展速度非常快,效力测定严格地强调需要对负责治疗作用机制的关键因素进行批判性分析,这为其提供了帮助。历史表明,要对作用机制有更深入的了解可能需要几十年的时间。然而,对精确靶点的追求彻底改变了医学,而在病毒大流行方面,没有比这更明显的例子了。在消灭天花的几个世纪里,为应对 COVID-19 大流行,疫苗的开发速度达到了前所未有的水平。这些非凡的成就鼓舞着人们相信,基于干细胞的治疗也将如此,我们的科学知识将继续快速提高。本章重点介绍实验和发现的艺术,介绍效力测定的要求以及可能影响效力测定结果的许多因素。全面了解效力测定及其发展可以加快提供新的细胞疗法,以帮助解决未满足医疗需求的负担性疾病。

相似文献

1
The Art of Stem Cell-Based Therapy.基于干细胞的治疗艺术。
Adv Exp Med Biol. 2023;1420:1-12. doi: 10.1007/978-3-031-30040-0_1.
2
Potency Assays: The 'Bugaboo' of Stem Cell Therapy.效力测定:干细胞治疗的“绊脚石”。
Adv Exp Med Biol. 2023;1420:29-38. doi: 10.1007/978-3-031-30040-0_3.
3
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
4
Potency assays and biomarkers for cell-based advanced therapy medicinal products.基于细胞的治疗性药物产品的效价测定和生物标志物。
Front Immunol. 2023 Jun 9;14:1186224. doi: 10.3389/fimmu.2023.1186224. eCollection 2023.
5
The Essential Need for a Validated Potency Assay for Cell-Based Therapies in Cardiac Regenerative and Reparative Medicine. A Practical Approach to Test Development.基于细胞的治疗在心脏再生和修复医学中的效力验证的必要需求。一种实用的测试开发方法。
Stem Cell Rev Rep. 2021 Dec;17(6):2235-2244. doi: 10.1007/s12015-021-10244-5. Epub 2021 Aug 31.
6
Illustrative Potency Assay Examples from Approved Therapies.获批治疗药物的效价测定实例。
Adv Exp Med Biol. 2023;1420:139-149. doi: 10.1007/978-3-031-30040-0_9.
7
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.干细胞疗法在严重 COVID-19 治疗中的效力。
Stem Cell Rev Rep. 2021 Feb;17(1):193-213. doi: 10.1007/s12015-020-10110-w. Epub 2021 Jan 28.
8
Bringing function to the forefront of cell therapy: how do we demonstrate potency?将功能置于细胞治疗的前沿:我们如何证明效力?
Front Immunol. 2023 Jul 11;14:1226841. doi: 10.3389/fimmu.2023.1226841. eCollection 2023.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
The Evolving Landscape of Potency Assays.效力测定的演进格局。
Adv Exp Med Biol. 2023;1420:165-189. doi: 10.1007/978-3-031-30040-0_11.

本文引用的文献

1
Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells.趋化因子分析基质定义了人骨髓间充质基质细胞的效力。
Stem Cells Transl Med. 2022 Sep 21;11(9):971-986. doi: 10.1093/stcltm/szac050.
2
Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing Mechanotransduction.增强间充质基质细胞效力:炎症许可的机械转导。
Front Immunol. 2022 Jul 6;13:874698. doi: 10.3389/fimmu.2022.874698. eCollection 2022.
3
Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression.
工程化免疫调节辅助细胞可改善实验性同种异体胰岛移植而无需免疫抑制。
Sci Adv. 2022 Jul 22;8(29):eabn0071. doi: 10.1126/sciadv.abn0071.
4
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19.间充质干细胞治疗 COVID-19 患者过度活跃的免疫反应。
Immunotherapy. 2022 Sep;14(13):1055-1065. doi: 10.2217/imt-2021-0245. Epub 2022 Jul 20.
5
The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review.漫长而曲折的道路:稳态与紊乱的造血微环境龛位:一篇综述
Biomater Transl. 2022 Mar 28;3(1):31-54. doi: 10.12336/biomatertransl.2022.01.005. eCollection 2022.
6
Advanced Therapy Medicinal Products and the Changing Role of Academia.先进治疗药物产品与学术界角色的转变
Transfus Med Hemother. 2022 May 16;49(3):158-162. doi: 10.1159/000524392. eCollection 2022 Jun.
7
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.优化间充质基质细胞(MSC)制造工艺以获得更好的治疗效果。
Front Immunol. 2022 Jun 9;13:918565. doi: 10.3389/fimmu.2022.918565. eCollection 2022.
8
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.间充质基质细胞治疗 COVID-19 诱导的 ARDS 患者:一项成功的 1 期、对照安慰剂组、临床试验。
Stem Cell Res Ther. 2022 Jun 28;13(1):283. doi: 10.1186/s13287-022-02920-1.
9
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval.更新的 COVID-19 间充质基质细胞治疗的对照试验的系统综述和荟萃分析:用于快速审批的试验证据加速综合(FASTER 审批)框架。
Stem Cells Transl Med. 2022 Jul 20;11(7):675-687. doi: 10.1093/stcltm/szac038.
10
Comparison of the 2021 International Society for Stem Cell Research (ISSCR) guidelines for "laboratory-based human stem cell research, embryo research, and related research activities" and the corresponding Japanese regulations.2021年国际干细胞研究学会(ISSCR)“基于实验室的人类干细胞研究、胚胎研究及相关研究活动”指南与日本相应法规的比较。
Regen Ther. 2022 Jun 3;21:46-51. doi: 10.1016/j.reth.2022.05.002. eCollection 2022 Dec.